Although IBC is considered a distinct clinicopathological entity, this disease shows significant heterogeneity at morphological (histological type, grade, and inflammatory infiltrate) and molecular (hormone receptor status and intrinsic molecular subtypes) levels [35]. Here, NR4A1 is linked to inflammatory breast carcinoma.